Literature DB >> 9558337

Hepatocyte growth factor/scatter factor has distinct classes of binding site in heparan sulfate from mammary cells.

H Rahmoune1, P S Rudland, J T Gallagher, D G Fernig.   

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) is a heparan sulfate (HS)-binding growth factor and morphogen for mammary epithelial cells that is produced by mammary stromal fibroblasts. HS chains, purified as peptidoglycans from a panel of cell lines representative of the ductal epithelial cell (Huma 123), the myoepithelial cell (Huma 109), the stromal fibroblast (Rama 27), and malignant mammary epithelial cells (MCF-7 and ZR-75), were used in a biosensor-based assay to identify the classes of HGF/SF-binding sites in the polysaccharide chains. At least three distinct binding sites were identified. One site exhibits fast association and fast dissociation kinetics [kass (1.4-7.7) x 10(6) M-1 s-1; kdiss 0. 0032-0.0096 s-1] and is present on the HS from benign Huma 123 epithelial cells, Huma 109 myoepithelial-like cells, and ZR-75 malignant cells. The second binding site, found on HS from the malignant MCF-7 cells, has slower HGF/SF-binding kinetics (kass 0.20 x 10(6) M-1 s-1; kdiss 0.00055 s-1). The third binding site possesses fast association and slow dissociation kinetics (kass 1.1 x 10(6) M-1 s-1; kdiss 0.00020 s-1) and was found on the HS isolated from the culture medium of the Huma 123 benign epithelial cells. The first and second binding sites have a similar Kd, 1-3 nM, while the third binding site has a considerably higher affinity for HGF/SF (Kd 200 pM). The three binding sites seem to be mutually exclusive, since each sample of HS possessed just one of the sites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558337     DOI: 10.1021/bi972468t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Use of a biosensor to determine the binding kinetics of five lectins for Galactosyl-N-acetylgalactosamine.

Authors:  J D Milton; D G Fernig; J M Rhodes
Journal:  Glycoconj J       Date:  2001-07       Impact factor: 2.916

2.  Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.

Authors:  Maryse Delehedde; Malcolm Lyon; John T Gallagher; Philip S Rudland; David G Fernig
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

Review 3.  Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland.

Authors:  M Delehedde; M Lyon; N Sergeant; H Rahmoune; D G Fernig
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

4.  Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex.

Authors:  S Baveye; E Elass; D G Fernig; C Blanquart; J Mazurier; D Legrand
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Interaction of metastasis-inducing S100A4 protein in vivo by fluorescence lifetime imaging microscopy.

Authors:  Shu Zhang; Guozheng Wang; David G Fernig; Philip S Rudland; Stephen E D Webb; Roger Barraclough; Marisa Martin-Fernandez
Journal:  Eur Biophys J       Date:  2004-08-03       Impact factor: 1.733

6.  Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung.

Authors:  S M Thompson; M G Connell; D G Fernig; G B Ten Dam; T H van Kuppevelt; J E Turnbull; E C Jesudason; P D Losty
Journal:  Pediatr Surg Int       Date:  2007-05       Impact factor: 2.003

7.  Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans.

Authors:  R van der Voort; R M Keehnen; E A Beuling; M Spaargaren; S T Pals
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

8.  Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.

Authors:  Valeria De Pasquale; Patrizia Sarogni; Valeria Pistorio; Giuliana Cerulo; Simona Paladino; Luigi Michele Pavone
Journal:  Mol Ther Methods Clin Dev       Date:  2018-06-18       Impact factor: 6.698

9.  Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.

Authors:  Maryse Delehedde; Lucie Devenyns; Claude-Alain Maurage; Romain R Vivès
Journal:  Int J Cell Biol       Date:  2013-03-28

Review 10.  Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression.

Authors:  Heydi Noriega-Guerra; Vanessa Morais Freitas
Journal:  Int J Mol Sci       Date:  2018-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.